Shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-two brokerages that are currently covering the company, ...

FY’24 results showcase growth potential with 12% IRR, strategic acquisitions, and undervalued stock. Read more on TMO stock ...

We recently published a list of the 10 Best Strong Buy Stocks To Buy Right Now. In this article, we are going to take a look ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

Citi lowered the firm’s price target on Thermo Fisher (TMO) to $570 from $650 and keeps a Neutral rating on the shares. The firm updated models in the life science tools and diagnostics group post the ...

Thermo Fisher Scientific CIO Ryan Snyder believes business strategy and tech strategy should be woven together and that data ...

The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, according to Marc N. Casper, chairman, president, and CEO of Thermo Fisher.

Explore Thermo Fisher Scientific Inc.'s valuation, modest growth challenges, and recent M&A moves. Click for my updated look ...

Thermo Fisher Scientific Inc. (NYSE:TMO) offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services. The one-month return of ...

Thermo Fisher Scientific (NYSE:TMO – Get Free Report) had its price target reduced by research analysts at Citigroup from ...

February 19, 2025--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE ... Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing ...

Thermo Fisher Scientific agreed to acquire Solventum's purification and filtration business for $4.1 billion in cash, confirming a report first made in The Wall Street Journal.